Who owns PYXS?
Institutional ownership of Pyxis Oncology Inc. from Form 13F, Q2 2026
76 institutional managers reported holding Pyxis Oncology Inc. (PYXS) in Form 13F filings for Q2 2026, with 34,152,124 shares worth $101M. The largest reported holder was GordonMD Global Investments LP. Managers that filed both quarters added a net 6,592,533 shares (+23.9%). 10 opened new positions and 10 sold out.
- Funds holding
- 76
- Value held
- $101M
- New / sold out
- 10 / 10
- Net shares, same filers
- +23.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PYXS
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| GordonMD Global Investments LP | $30.2M | 29.4% | 10,024,909 | Added |
| Pfizer Inc | $19.5M | 20.6% | 7,032,770 | Unchanged |
| Laurion Capital Management LP | $14.8M | 14.4% | 4,900,888 | Trimmed |
| Vanguard Capital Management LLC | $6.2M | 6.1% | 2,075,997 | Added |
| Atle Fund Management AB | $2.9M | 2.8% | 966,459 | Added |
| BlackRock, Inc. | $2.6M | 2.5% | 867,934 | Added |
| Palo Alto Investors LP | $2.6M | 2.5% | 864,277 | Trimmed |
| Marshall Wace, LLP | $2.5M | 2.4% | 830,544 | Added |
| Renaissance Technologies LLC | $2.3M | 2.3% | 772,232 | Trimmed |
| Geode Capital Management, LLC | $1.8M | 1.7% | 591,849 | Trimmed |
| Woodline Partners LP | $1.6M | 1.5% | 523,999 | New |
| 683 Capital Management, LLC | $1.4M | 1.3% | 459,367 | Trimmed |
| Jacobs Levy Equity Management, Inc | $1.3M | 1.3% | 428,606 | Trimmed |
| Longaeva Partners L.P. | $1.1M | 1.0% | 353,582 | Trimmed |
| Decheng Capital LLC | $984K | 1.0% | 326,810 | Unchanged |
| Vanguard Fiduciary Trust Co | $912K | 0.9% | 302,986 | Added |
| Jane Street Group, LLC | $873K | 0.8% | 290,090 | Trimmed |
| State Street Corp | $749K | 0.7% | 248,837 | Unchanged |
| Millennium Management LLC | $701K | 0.7% | 233,004 | Trimmed |
| UBS Group AG | $467K | 0.5% | 155,217 | Trimmed |
| Bank of New York Mellon Corp | $403K | 0.4% | 133,996 | Unchanged |
| Acadian Asset Management LLC | $380K | 0.4% | 126,793 | Trimmed |
| Northern Trust Corp | $373K | 0.4% | 123,959 | Added |
| NewEdge Wealth, LLC | $349K | 0.3% | 116,006 | Unchanged |
| XTX Topco Ltd | $334K | 0.3% | 110,939 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 34,152,124 PYXS shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- GordonMD Global Investments LP Added+$17.8M
- Atle Fund Management AB Added+$2.3M
- Woodline Partners LP New+$1.6M
- Marshall Wace, LLP Added+$1.4M
- BlackRock, Inc. Added+$238K
- Bank of America Corp Added+$192K
- MYDA Advisors LLC New+$151K
- Quadrature Capital Ltd New+$142K
- Verdad Advisers, LP New+$135K
- Vanguard Capital Management LLC Added+$128K
Biggest sellers in Q2 2026
- 683 Capital Management, LLC Trimmed-$1.3M
- Millennium Management LLC Trimmed-$496K
- Longaeva Partners L.P. Trimmed-$450K
- Palo Alto Investors LP Trimmed-$440K
- Renaissance Technologies LLC Trimmed-$351K
- UBS Group AG Trimmed-$298K
- Laurion Capital Management LP Trimmed-$290K
- XTX Topco Ltd Trimmed-$268K
- Barclays PLC Trimmed-$136K
- Morgan Stanley Trimmed-$109K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $25.0M and sold $4.8M; 24 added and 24 trimmed.
Schedule 13D and 13G filings on PYXS
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16ORBIMED ADVISORS LLC SCHEDULE 13G filed by Pyxis Oncology Inc.Schedule 13G
- 2026-11-16RTW INVESTMENTS, LP SCHEDULE 13G filed by Pyxis Oncology Inc.Schedule 13G
- 2026-07-10BIOTECHNOLOGY VALUE FUND L P SCHEDULE 13G filed by Pyxis Oncology Inc.Schedule 13G
- 2025-07-01MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Pyxis Oncology Inc.Schedule 13G
- 2025-02-04BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
Questions about PYXS ownership
- Who owns PYXS stock?
- 76 institutional investment managers reported PYXS positions in their Form 13F filings for Q2 2026, holding 34,152,124 shares worth $101M in total. GordonMD Global Investments LP reported the largest position.
- Are funds buying or selling PYXS?
- In Q2 2026, 10 managers opened new PYXS positions, 24 added, 24 trimmed and 10 sold out. Managers that filed in both quarters added a net 6,592,533 shares.
- How current is this PYXS institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PYXS by CUSIP. Options are left out. PYXS news and filings · PYXS insider trades · Top funds